Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,012 total articles
Monster Beverage (MNST) is trading near $96 and offers a tradeable setup that buys into durable free cash flow, category growth and strong liquidity. Valuation is rich but not irrational given 2026 growth and zero net debt. This idea is a mid-term long: entry $96.23, stop $90.00, target $110.00 over ~45 trading days.
Alibaba is trading at $110.995 with a market cap of $268.1B and a PE of 16.96. Recent momentum, improving technicals, and analyst optimism around cloud and local consumer services create a tactical long opportunity. The trade banks on quick-commerce losses narrowing and margin leverage to prompt upward EPS revisions and multiple expansion over a 18…
Prime Medicine's legal win versus a competitor reduces a key overhang and improves the risk/reward for long investors. The company still trades like an early-stage biotech: negative EPS, negative free cash flow, and a market cap near $830M. For disciplined traders, a long trade with a $4.60 entry, $7.50 target and $3.60 stop over a 180 trading-day …
IREN is a vertically integrated, renewable-powered data center operator that has rapidly expanded its pipeline through acquisitions and large customer commitments. Despite a frothy multiple and recent volatility, IREN's announced capacity wins, European entry and a growing neocloud narrative create a time-limited opportunity. This trade targets a r…
<p>Campbell's (CPB) looks like a classic income-and-value trade: a roughly $6.5B consumer food company trading at ~11x earnings, producing meaningful free cash flow and paying a 7% yield while the market punishes near-term growth concerns. The risk/reward is asymmetric for an investor willing to accept some operational drag in exchange for yield an…
JD.com is trading at a valuation that looks reasonable for a dominant logistics-enabled e-commerce platform. Strong cashflow characteristics, a 3.55% dividend yield and signs of bullish technical momentum make a mid-term long trade attractive. Entry at $27.50, target $33.00, stop $25.50 — horizon 45 trading days.
ServiceNow (NOW) sold off sharply in H1 2026 but still posts high-teens to low-20s subscription growth, strong free cash flow, and early AI product monetization. I outline a trade with a $106.64 entry, $84.00 stop, and $150.00 target over a 180-trading-day horizon, driven by product execution, re-rating potential, and improving technical momentum.
Kraken Robotics has delivered strong growth and won repeat naval orders, but the stock is trading like a strategic takeover candidate. With price below key moving averages, elevated valuation versus near-term revenue and recent equity dilution, we favor a tactical short over the mid-term until proof of enduring margin expansion or strategic consoli…
Modine's shares have pulled back from the froth of the spring rally. That weakness is a buying opportunity. A large hyperscaler contract, accelerating data-center cooling demand driven by AI, and a planned spinoff of lower-margin operations support re-rating. Valuation is rich today, but the revenue and cash-flow lift expected in 2027–2029 justify …
Stryker ($SYK) reported a disrupted quarter that sent the stock down from its 52-week highs. The fundamentals - $125B market cap, $4.57B free cash flow, 14.5% ROE - argue for patience. This trade buys the dip with a clear entry, stop and $375 target, expecting normalization in procedure volumes, benefits from the Amplitude Vascular acquisition, and…
Yellow Cake is a play on physical uranium exposure with a newly credible catalyst - a share buyback program - that should compress the long-standing discount to NAV and create a clear path for upside. This trade plan lays out an entry at $5.20, stop at $3.90 and target at $8.50 with a primary horizon of 180 trading days.
T-Mobile is trading at roughly $179 and offers a compelling risk-reward: strong free cash flow ($18.2B), mid-teens ROE, and an EV/EBITDA of 8.7. Those fundamentals, combined with durable postpaid economics and a 2.2% yield, argue for a multiple expansion trade toward $224 over the next several months. Manageable leverage and a clear stop beneath th…
<p>Micron is at the center of an intensifying memory cycle driven by AI data-center demand and constrained supply. The company’s expansion plan and strong cash flow profile give it real leverage as high-bandwidth memory (HBM) and DRAM tightness push pricing power higher. This trade idea outlines a mid-term long entry at near-term prices with a defi…
Nomura's pivot toward global asset management and steady wholesale performance, combined with a modest valuation (market cap ~$29.7B, P/E ~12), supports a long trade. Entry at $9.54, stop at $8.50 and a $11.50 target over a long-term horizon (180 trading days) captures integration upside, fee growth and potential multiple expansion while acknowledg…
Novo Nordisk’s move to an oral Wegovy offering ramps competitive pressure on Eli Lilly but also crystallizes the company’s multi-channel defense. At current levels near $48.90, the stock looks like a mid-term buy: attractive valuation for a market-cap leader ($220.3B), supportive technicals and rising short interest give upside with defined risk. T…
Planet Labs launched Pelican-11, a step that could improve imagery cadence and product stickiness. The stock trades at a premium – market cap near $9.9B and price-to-sales of about 29.5x – but positive free cash flow, improving technicals, and a concentrated short base make a tactical long attractive. This trade plan lays out entry, target, and sto…
POWI is a high-quality analog semiconductor exposed to industrial, automotive and consumer power conversion markets. The core thesis is a recovery in industrial power spending and margin tailwinds from restructuring; Nvidia-related design wins are a high-impact optionality, not the base case. Valuation is rich today, so this trade uses a defined en…
Moelis & Company (MC) trades near $64.63 after a sharp two-session selloff. The firm combines high return on equity, robust free cash flow and zero debt with a meaningful dividend yield, creating a case for a defined-risk long trade. Entry at $64.63 with a $60 stop and a $78.22 target offers asymmetric upside while limiting capital at risk.
DocuSign is trading like a growth liability rather than a profitable SaaS with attractive cash flow. With market cap near $9.0B, positive free cash flow of ~$1.12B, improving profitability and an AI-driven Intelligent Agreement Management (IAM) business already at ~12.6% of ARR, the current setup favors a tactical long. We upgrade to BUY for a mid-…
Magellan Aerospace has the structural setup investors should like: steady defense contracts, improving commercial OEM demand, and a manufacturing footprint that benefits program wins and aftermarket growth. This trade idea lays out an entry at $8.50, a $13.00 target and a $6.50 stop for a long-term push over the next 180 trading days.
Novo Nordisk looks oversold relative to its market position. At roughly $220.3B market cap, a 11.6x P/E and 2.48% yield create a compelling risk-reward for a long trade while the company consolidates after a sharp multi-month pullback.
Bank of America passed the Fed stress tests, trades at a reasonable multiple with a $413.8B market cap, and has technical momentum. A convertible-preferred-style exposure (or owning the common as a proxy) captures yield today and upside if common equity rerates. Trade plan provided with entry, stop and target for a long-duration trade.
Best Buy reported a better-than-expected Q1 with revenue of $8.94B, comparable sales +2%, and margin expansion. At $78, the stock offers a near-5% yield and reasonable valuation metrics (P/E ~14.4, EV/EBITDA ~6.1), making a short-to-mid-term income trade attractive. Upside to the prior highs is limited, so this is a yield-first, risk-managed long r…
Argan (AGX) is benefiting from the AI-driven surge in power and data-center construction. With a $2.9B backlog, 50% revenue growth year-over-year and strong free cash flow, the company has the fundamentals to support further gains. That said, lofty multiples and a short-term technical pullback argue for an entry with a tight stop and a clearly defi…
Strategic Education (STRA) is transitioning from a largely consumer-facing higher-education company toward recurring B2B revenue via employer-sponsored education programs. Valuation is reasonable (P/E ~14.4, EV/EBITDA 7), free cash flow is healthy ($173.9M), and technicals are constructive. I view STRA as a buy with an explicit entry, stop and targ…
